[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +9%
1 Month: XX% +4%
6 Months: XX% +9%
1 Year: XX% +16%
1-Year High: XX% on 2025-07-08
1-Year Low: XX% on 2025-06-24
Most Supportive Themes
- Eli Lilly's Investment in India: (35%) Eli Lilly's commitment to invest over $X billion in India to expand manufacturing and supply chains, particularly for Mounjaro, is viewed positively.
- Positive Sentiment on Weight Loss Drugs: (30%) The success of Eli Lilly's weight loss drugs, Zepbound and Mounjaro, and the potential of their oral pill, orforglipron, generate positive sentiment.
- FDA Official Joins Eli Lilly: (15%) The hiring of a former FDA official by Eli Lilly is seen as a positive move, potentially strengthening the company's research and development.
Most Critical Themes
- Price Increase Concerns: (10%) The announced price increase for Mounjaro in the UK has sparked concerns about accessibility and affordability.
- Competition and Market Dynamics: (10%) Competition from Novo Nordisk and other players in the weight loss market, along with potential regulatory and pricing pressures, pose risks.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXXX | XX% | XXXXXXX | XX% | XXXXXX | X% |
| TikTok | XXXXX | X% | XXXXXX | XX% | XXXXX | X% |
| XX | X% | X | X% | X | X% | |
| YouTube | XXXXX | X% | XXXXX | X% | XXX | X% |
| News | XXXXXX | X% | XXXXX | X% | XXX | X% |
| Total | XXXXXXX | XX% | XXXXXXX | XX% | XXXXXX | X% |